Clinical Trials Browser

Phase 1/2 × Recurrence × TIC10 compound × Clear all

NCT03492138 2020-05-29

Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

Multiple Myeloma, Recurrence